Showing 15,441 - 15,460 results of 31,914 for search '(( 50 ((((ns decrease) OR (we decrease))) OR (a decrease)) ) OR ( e point decrease ))', query time: 1.12s Refine Results
  1. 15441

    Data_Sheet_1_Effects of COVID-19-targeted non-pharmaceutical interventions on pediatric hospital admissions in North Italian hospitals, 2017 to 2022: a quasi-experimental study int... by Giuseppe Maglietta (12992976)

    Published 2024
    “…Level change for Mental Disorders significantly decreased during school closure (HRR 0.50, 95%CI 0.30–0.82) but increased during mitigation measures by 28% (HRR 1.28, 95%CI 0.98–1.69).…”
  2. 15442

    Data_Sheet_1_Effects of COVID-19-targeted non-pharmaceutical interventions on pediatric hospital admissions in North Italian hospitals, 2017 to 2022: a quasi-experimental study int... by Giuseppe Maglietta (12992976)

    Published 2024
    “…Level change for Mental Disorders significantly decreased during school closure (HRR 0.50, 95%CI 0.30–0.82) but increased during mitigation measures by 28% (HRR 1.28, 95%CI 0.98–1.69).…”
  3. 15443

    Data_Sheet_1_Effects of COVID-19-targeted non-pharmaceutical interventions on pediatric hospital admissions in North Italian hospitals, 2017 to 2022: a quasi-experimental study int... by Giuseppe Maglietta (12992976)

    Published 2024
    “…Level change for Mental Disorders significantly decreased during school closure (HRR 0.50, 95%CI 0.30–0.82) but increased during mitigation measures by 28% (HRR 1.28, 95%CI 0.98–1.69).…”
  4. 15444

    Data_Sheet_1_Effects of COVID-19-targeted non-pharmaceutical interventions on pediatric hospital admissions in North Italian hospitals, 2017 to 2022: a quasi-experimental study int... by Giuseppe Maglietta (12992976)

    Published 2024
    “…Level change for Mental Disorders significantly decreased during school closure (HRR 0.50, 95%CI 0.30–0.82) but increased during mitigation measures by 28% (HRR 1.28, 95%CI 0.98–1.69).…”
  5. 15445

    Data_Sheet_1_Effects of COVID-19-targeted non-pharmaceutical interventions on pediatric hospital admissions in North Italian hospitals, 2017 to 2022: a quasi-experimental study int... by Giuseppe Maglietta (12992976)

    Published 2024
    “…Level change for Mental Disorders significantly decreased during school closure (HRR 0.50, 95%CI 0.30–0.82) but increased during mitigation measures by 28% (HRR 1.28, 95%CI 0.98–1.69).…”
  6. 15446

    Data_Sheet_1_Effects of COVID-19-targeted non-pharmaceutical interventions on pediatric hospital admissions in North Italian hospitals, 2017 to 2022: a quasi-experimental study int... by Giuseppe Maglietta (12992976)

    Published 2024
    “…Level change for Mental Disorders significantly decreased during school closure (HRR 0.50, 95%CI 0.30–0.82) but increased during mitigation measures by 28% (HRR 1.28, 95%CI 0.98–1.69).…”
  7. 15447

    Figure S1 - A Prolyl-Hydroxylase Inhibitor, Ethyl-3,4-Dihydroxybenzoate, Induces Cell Autophagy and Apoptosis in Esophageal Squamous Cell Carcinoma Cells via Up-Regulation of BNIP3... by Bo Han (84102)

    Published 2014
    “…<p><b>Gene expression profile analysis of EDHB-treated KYSE 170 cells.</b> (A) Heat map of overlapping genes. Red/green indicate an increase/decrease in gene expression relative to the universal mean for each gene. …”
  8. 15448
  9. 15449
  10. 15450
  11. 15451
  12. 15452

    DataSheet_1_Free Versus Fixed-Ratio Combination of Basal Insulin and GLP-1 Receptor Agonists in Type 2 Diabetes Uncontrolled With GLP-1 Receptor Agonists: A Systematic Review and I... by Han Na Jung (9942484)

    Published 2022
    “…No significant differences were discovered between the two methods regarding the decrease in HbA1c (WMD 0.08%, 95% CI −1.07% to 1.23%), FPG (WMD −2.29 mg/dl, 95% CI −45.07 to 40.49 mg/dl), target achievement (RR 1.03, 95% CI 0.50−2.14), and hypoglycemic risk (RR 0.32, 95% CI 0.03−3.59).…”
  13. 15453

    Data_Sheet_1_Diabetes-specific formula with standard of care improves glycemic control, body composition, and cardiometabolic risk factors in overweight and obese adults with type... by Siew Ling Tey (7480985)

    Published 2024
    “…This randomized controlled trial investigated the effects of a diabetes-specific formula (DSF) on glycemic control and cardiometabolic risk factors in adults with type 2 diabetes (T2D).…”
  14. 15454

    Presentation_1_A Long Non-coding RNA, LOC157273, Is an Effector Transcript at the Chromosome 8p23.1-PPP1R3B Metabolic Traits and Type 2 Diabetes Risk Locus.pdf by Alisa K. Manning (7634102)

    Published 2020
    “…</p>Results<p>We found that siRNA knockdown decreased LOC157273 transcript levels by approximately 80%, increased PPP1R3B mRNA levels by 1.7-fold, and increased glycogen deposition by >50% in primary human hepatocytes. …”
  15. 15455

    Table_1_A Long Non-coding RNA, LOC157273, Is an Effector Transcript at the Chromosome 8p23.1-PPP1R3B Metabolic Traits and Type 2 Diabetes Risk Locus.xlsx by Alisa K. Manning (7634102)

    Published 2020
    “…</p>Results<p>We found that siRNA knockdown decreased LOC157273 transcript levels by approximately 80%, increased PPP1R3B mRNA levels by 1.7-fold, and increased glycogen deposition by >50% in primary human hepatocytes. …”
  16. 15456
  17. 15457

    High-throughput screening and <i>in vitro</i> evaluation of CSB-0914; a novel small molecule NF-κB inhibitor attenuating inflammatory responses through NF-κB, Nrf2 and HO-1 cross-t... by Mesfer Al Shahrani (13774273)

    Published 2023
    “…The compound demonstrated significant efficacy in reducing basophil activation assay induced by FcεRI receptors, with an IC50 value of 98.41 nM.. A dose dependent decrease in neutrophil migration and elastase were observed when treated with CSB- 0914. …”
  18. 15458

    DataSheet_1_Multi-b-values-fitting readout-segmentation of long variable echo-trains diffusion-weighted imaging (RESOLVE DWI) in evaluation of disease activity and curative effect... by Xianyuan Chen (16482096)

    Published 2023
    “…</p>Conclusion<p>Multi-b-values-fitting (b=50,500,700s/mm<sup>2</sup>) RESOLVE DWI has a certain advantage in evaluating disease activity of axSpA. …”
  19. 15459
  20. 15460

    Table1_Pharmacokinetic herb-drug interactions: Altered systemic exposure and tissue distribution of ciprofloxacin, a substrate of multiple transporters, after combined treatment wi... by Ziqiang Li (247218)

    Published 2022
    “…</p><p>Results: Concurrent use of PCE substantially reduced circulating CIP (approximately 40%–50%) in humans and rats, while CIP hardly changed circulating GA and PCA. …”